Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 298-312
Closed Access | Times Cited: 968
Deregulation of HLA-I in cancer and its central importance for immunotherapy
Ahmet Hazini, Kerry Fisher, Leonard W. Seymour
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e002899-e002899
Open Access | Times Cited: 138
Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Xiangyu Wu, Tianhang Li, Rui Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 61
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
Katrin Pansy, Barbara Uhl, Jelena Krstić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13311-13311
Open Access | Times Cited: 81
HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
Baimei Zhuang, Jin Shang, Yuanqing Yao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 45
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
Fabio Morandi, Irma Airoldi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2925-2925
Open Access | Times Cited: 30
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events
Ning Jiang, Yue Yu, Dawei Wu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 2, pp. 737-747
Closed Access | Times Cited: 16
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
Moksada Regmi, Yingjie Wang, Weihai Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 6
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
Jiji V. D. Attia, Charlotte E. Dessens, Ricky B. van de Water, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8678-8678
Open Access | Times Cited: 40
NKG2A‐checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA‐E
Claire Battin, Gabriel Kaufmann, Judith Leitner, et al.
Immunology (2022) Vol. 166, Iss. 4, pp. 507-521
Open Access | Times Cited: 26
NK cells in the brain: implications for brain tumor development and therapy
Agisilaos Balatsoukas, Filippo Rossignoli, Khalid Shah
Trends in Molecular Medicine (2022) Vol. 28, Iss. 3, pp. 194-209
Open Access | Times Cited: 22
Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
Ben Umiker, Yasmin Hashambhoy-Ramsay, Jeff Smith, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 471-484
Open Access | Times Cited: 14
Corporate genome screening India (CoGsI) identified genetic variants association with T2D in young Indian professionals
Shah Fahad Husami, Tarundeep Kaur, Love Gupta, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Triple-Negative Breast Cancer Systemic Treatment: Disruptive Early-Stage Developments for Overcoming Stagnation in the Advanced Pipeline
Carlos Alonso-Ron, Andrea Vethencourt, Eva González‐Suárez, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 633-633
Open Access
Old and New Players of Inflammation and Their Relationship With Cancer Development
Rodolfo Chavez-Dominguez, Mario Perez-Medina, Dolores Aguilar-Cázares, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
Simon Jasinski-Bergner, Markus Eckstein, Helge Taubert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes
Huihui Xu, Huili Wang, Tong-Jin Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Role of HLA-G in tumors and upon COVID-19 infection
Barbara Seliger
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110792-110792
Open Access | Times Cited: 3
Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
Wenwen Yang, Caining Lei, Shaoming Song, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR Signaling
Vrouyr Bilemjian, Martijn Vlaming, Jimena Álvarez Freile, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3164-3164
Open Access | Times Cited: 15
RNA m6A modifications regulate crosstalk between tumor metabolism and immunity
Jinghua Gu, Huake Cao, Xiaoli Chen, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients
Vladimı́ra Ďurmanová, Miroslav Tedla, Dusan Rada, et al.
Diseases (2024) Vol. 12, Iss. 2, pp. 34-34
Open Access | Times Cited: 2
Certain haplotypes of the 3′-UTR region of the HLA-G gene are linked to breast cancer
Mehdi Haghi, Mahdi Ranjbar, Kazhal Karari, et al.
British Journal of Biomedical Science (2021) Vol. 78, Iss. 2, pp. 87-91
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top